HOPPER JONATHAN MARK (Chief Medical Officer) sold 13.1% of their position (10K shares) of VERICEL CORP on the open market
Open‑market sale worth $495.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/5/2025ACC: 0001140361-25-007179
Officer· Chief Medical Officer
Since Feb 2020
+10K
Net shares
Net buyer
$495.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
20K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$18.00
Trade value
$180K
% of position
15.1%
3/3/2025
66.10K→76.10K
Common Stock
Direct
Shares
−10K
Price / share
$49.53
Trade value
$495.30K
% of position
13.1%
3/3/2025
76.10K→66.10K
Total
Net shares
+0.00
Net value
-$315.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2025 | M · Option Exercise | +10K | $18.00 | $180K | 15.1% | 66.10K | 76.10K |
| Common Stock Direct | 3/3/2025 | S · Sale | −10K | $49.53 | $495.30K | 13.1% | 76.10K | 66.10K |
| Total | +0.00 | -$315.30K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10K shares
Shares
+10K
Strike price
18
Held after
28.75K
Exercisable
—
3/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock10K shares | 3/3/2025 | M · Option Exercise | +10K | 18 | — | 28.75K |